Luigi Messori - Publications

Affiliations: 
Dipartimento di Chimica "Ugo Schiff" University of Florence, Firenze, Toscana, Italy 

129 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Geri A, Zineddu S, Massai L, Ronga L, Lobinski R, Gailer J, Messori L. Mercury binding to proteins disclosed by ESI MS experiments: The case of three organomercurials. Journal of Inorganic Biochemistry. 252: 112479. PMID 38218139 DOI: 10.1016/j.jinorgbio.2024.112479  0.302
2023 Cirri D, Geri A, Massai L, Mannelli M, Gamberi T, Magherini F, Becatti M, Gabbiani C, Pratesi A, Messori L. Chemical Modification of Auranofin Yields a New Family of Anticancer Drug Candidates: The Gold(I) Phosphite Analogues. Molecules (Basel, Switzerland). 28. PMID 36770719 DOI: 10.3390/molecules28031050  0.307
2021 Mazzei L, Massai L, Cianci M, Messori L, Ciurli S. Medicinal Au(I) compounds targeting urease as prospective antimicrobial agents: unveiling the structural basis for enzyme inhibition. Dalton Transactions (Cambridge, England : 2003). PMID 34585201 DOI: 10.1039/d1dt02488d  0.515
2021 Mazzei L, Cirri D, Cianci M, Messori L, Ciurli S. Kinetic and structural analysis of the inactivation of urease by mixed-ligand phosphine halide Ag(I) complexes. Journal of Inorganic Biochemistry. 218: 111375. PMID 33711632 DOI: 10.1016/j.jinorgbio.2021.111375  0.526
2020 Massai L, Zoppi C, Cirri D, Pratesi A, Messori L. Reactions of Medicinal Gold(III) Compounds With Proteins and Peptides Explored by Electrospray Ionization Mass Spectrometry and Complementary Biophysical Methods. Frontiers in Chemistry. 8: 581648. PMID 33195070 DOI: 10.3389/fchem.2020.581648  0.327
2020 Ferraro G, Pratesi A, Messori L, Merlino A. Protein interactions of dirhodium tetraacetate: a structural study. Dalton Transactions (Cambridge, England : 2003). PMID 32022076 DOI: 10.1039/c9dt04819g  0.303
2019 Ferraro G, Marzo T, Cucciolito ME, Ruffo F, Messori L, Merlino A. Reaction with Proteins of a Five-Coordinate Platinum(II) Compound. International Journal of Molecular Sciences. 20. PMID 30691130 DOI: 10.3390/ijms20030520  0.308
2018 Savić A, Marzo T, Scaletti F, Massai L, Bartoli G, Hoogenboom R, Messori L, Van Deun R, Van Hecke K. New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules. Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine. PMID 30367340 DOI: 10.1007/S10534-018-0155-X  0.326
2017 Marzo T, De Pascali SA, Gabbiani C, Fanizzi FP, Messori L, Pratesi A. ESI-MS studies of the reactions of novel platinum(II) complexes containing O,O'-chelated acetylacetonate and sulfur ligands with selected model proteins. Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine. PMID 28677079 DOI: 10.1007/s10534-017-0031-0  0.309
2016 Massai L, Cirri D, Michelucci E, Bartoli G, Guerri A, Cinellu MA, Cocco F, Gabbiani C, Messori L. Organogold(III) compounds as experimental anticancer agents: chemical and biological profiles. Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine. PMID 27476157 DOI: 10.1007/s10534-016-9957-x  0.331
2016 Gothe Y, Marzo T, Messori L, Metzler-Nolte N. Iridium(I) Compounds as Prospective Anticancer Agents: Solution Chemistry, Antiproliferative Profiles and Protein Interactions for a Series of Iridium(I) N-Heterocyclic Carbene Complexes. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 27443984 DOI: 10.1002/Chem.201601542  0.329
2016 Gabbiani C, Pratesi A, Marchetti L, Casini A, Leoni P, Pillozzi S, Crociani O, Bartoli G, Messori L. Potent in vitro antiproliferative properties for a triplatinum cluster toward triple negative breast cancer cells. Journal of Inorganic Biochemistry. PMID 27381671 DOI: 10.1016/J.Jinorgbio.2016.06.024  0.503
2016 Bazzicalupi C, Ferraroni M, Papi F, Massai L, Bertrand B, Messori L, Gratteri P, Casini A. Determinants for Tight and Selective Binding of a Medicinal Dicarbene Gold(I) Complex to a Telomeric DNA G-Quadruplex: a Joint ESI MS and XRD Investigation. Angewandte Chemie (International Ed. in English). PMID 26929051 DOI: 10.1002/Anie.201511999  0.524
2016 Mügge C, Musumeci D, Michelucci E, Porru F, Marzo T, Massai L, Messori L, Weigand W, Montesarchio D. Elucidating the reactivity of Pt(II) complexes with (O,S) bidentate ligands towards DNA model systems. Journal of Inorganic Biochemistry. 160: 198-209. PMID 26921982 DOI: 10.1016/J.Jinorgbio.2016.02.013  0.303
2016 Battistin F, Scaletti F, Balducci G, Pillozzi S, Arcangeli A, Messori L, Alessio E. Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties. Journal of Inorganic Biochemistry. PMID 26920229 DOI: 10.1016/J.Jinorgbio.2016.02.009  0.353
2016 Serratrice M, Maiore L, Zucca A, Stoccoro S, Landini I, Mini E, Massai L, Ferraro G, Merlino A, Messori L, Cinellu MA. Cytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivatives. Dalton Transactions (Cambridge, England : 2003). 45: 579-90. PMID 26609781 DOI: 10.1039/c5dt02714d  0.325
2016 Mügge C, Musumeci D, Michelucci E, Porru F, Marzo T, Massai L, Messori L, Weigand W, Montesarchio D. Elucidating the reactivity of Pt(II) complexes with (O,S) bidentate ligands towards DNA model systems Journal of Inorganic Biochemistry. 160: 198-209. DOI: 10.1016/j.jinorgbio.2016.02.013  0.301
2015 Massai L, Fernández-Gallardo J, Guerri A, Arcangeli A, Pillozzi S, Contel M, Messori L. Design, synthesis and characterisation of new chimeric ruthenium(II)-gold(I) complexes as improved cytotoxic agents. Dalton Transactions (Cambridge, England : 2003). 44: 11067-76. PMID 25996553 DOI: 10.1039/C5Dt01614B  0.321
2014 Russo Krauss I, Messori L, Cinellu MA, Marasco D, Sirignano R, Merlino A. Interactions of gold-based drugs with proteins: The structure and stability of the adduct formed in the reaction between lysozyme and the cytotoxic gold(iii) compound Auoxo3 Dalton Transactions. 43: 17483-17488. PMID 25340580 DOI: 10.1039/c4dt02332c  0.33
2014 Messori L, Cinellu MA, Merlino A. Protein Recognition of Gold-Based Drugs: 3D Structure of the Complex Formed When Lysozyme Reacts with Aubipy(c.). Acs Medicinal Chemistry Letters. 5: 1110-3. PMID 25313321 DOI: 10.1021/ml500231b  0.339
2014 Messori L, Marzo T, Michelucci E, Russo Krauss I, Navarro-Ranninger C, Quiroga AG, Merlino A. Interactions between anticancer trans-platinum compounds and proteins: crystal structures and ESI-MS spectra of two protein adducts of trans-(dimethylamino)(methylamino)dichloridoplatinum(II). Inorganic Chemistry. 53: 7806-8. PMID 25025479 DOI: 10.1021/Ic5012583  0.309
2014 Messori L, Marzo T, Sanches RN, de Oliveira Silva D, Merlino A. Unusual structural features in the lysozyme derivative of the tetrakis(acetato)chloridodiruthenium(II,III) complex. Angewandte Chemie (International Ed. in English). 53: 6172-5. PMID 24796316 DOI: 10.1002/anie.201403337  0.307
2014 De March M, Demitri N, De Zorzi R, Casini A, Gabbiani C, Guerri A, Messori L, Geremia S. Nitrate as a probe of cytochrome c surface: crystallographic identification of crucial "hot spots" for protein-protein recognition. Journal of Inorganic Biochemistry. 135: 58-67. PMID 24662464 DOI: 10.1016/J.Jinorgbio.2014.02.015  0.508
2014 Messori L, Marchetti L, Massai L, Scaletti F, Guerri A, Landini I, Nobili S, Perrone G, Mini E, Leoni P, Pasquali M, Gabbiani C. Chemistry and biology of two novel gold(I) carbene complexes as prospective anticancer agents. Inorganic Chemistry. 53: 2396-403. PMID 24547701 DOI: 10.1021/Ic401731A  0.35
2014 Tamasi G, Bernini C, Corbini G, Owens NF, Messori L, Scaletti F, Massai L, Giudice PL, Cini R. Synthesis, spectroscopic and DFT structural characterization of two novel ruthenium(III) oxicam complexes. In vivo evaluation of anti-inflammatory and gastric damaging activities. Journal of Inorganic Biochemistry. 134: 25-35. PMID 24518539 DOI: 10.1016/J.Jinorgbio.2014.01.011  0.322
2014 Messori L, Scaletti F, Massai L, Cinellu MA, Russo Krauss I, di Martino G, Vergara A, Paduano L, Merlino A. Interactions of gold-based drugs with proteins: crystal structure of the adduct formed between ribonuclease A and a cytotoxic gold(III) compound. Metallomics : Integrated Biometal Science. 6: 233-6. PMID 24287583 DOI: 10.1039/C3Mt00265A  0.301
2014 Mügge C, Liu R, Görls H, Gabbiani C, Michelucci E, Rüdiger N, Clement JH, Messori L, Weigand W. Novel platinum(II) compounds with O,S bidentate ligands: synthesis, characterization, antiproliferative properties and biomolecular interactions. Dalton Transactions (Cambridge, England : 2003). 43: 3072-86. PMID 24169734 DOI: 10.1039/C3Dt52284A  0.342
2014 Messori L, Marchetti L, Massai L, Scaletti F, Guerri A, Landini I, Nobili S, Perrone G, Mini E, Leoni P, Pasquali M, Gabbiani C. Chemistry and biology of two novel gold(I) carbene complexes as prospective anticancer agents Inorganic Chemistry. 53: 2396-2403. DOI: 10.1021/ic401731a  0.349
2013 Guidi F, Modesti A, Landini I, Nobili S, Mini E, Bini L, Puglia M, Casini A, Dyson PJ, Gabbiani C, Messori L. The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomics. Journal of Inorganic Biochemistry. 118: 94-9. PMID 23142974 DOI: 10.1016/J.Jinorgbio.2012.10.003  0.52
2012 Messori L, Cubo L, Gabbiani C, Álvarez-Valdés A, Michelucci E, Pieraccini G, Ríos-Luci C, León LG, Padrón JM, Navarro-Ranninger C, Casini A, Quiroga AG. Reactivity and biological properties of a series of cytotoxic PtI2(amine)2 complexes, either cis or trans configured. Inorganic Chemistry. 51: 1717-26. PMID 22225466 DOI: 10.1021/Ic202036C  0.553
2011 Maiore L, Cinellu MA, Nobili S, Landini I, Mini E, Gabbiani C, Messori L. Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: solution behavior, reactions with model proteins, antiproliferative properties. Journal of Inorganic Biochemistry. 108: 123-7. PMID 22173093 DOI: 10.1016/j.jinorgbio.2011.11.007  0.328
2011 Casini A, Messori L. Molecular mechanisms and proposed targets for selected anticancer gold compounds. Current Topics in Medicinal Chemistry. 11: 2647-60. PMID 22039866 DOI: 10.2174/156802611798040732  0.529
2011 Gabbiani C, Casini A, Kelter G, Cocco F, Cinellu MA, Fiebig HH, Messori L. Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability. Metallomics : Integrated Biometal Science. 3: 1318-23. PMID 21887452 DOI: 10.1039/C1Mt00113B  0.533
2011 Maiore L, Cinellu MA, Michelucci E, Moneti G, Nobili S, Landini I, Mini E, Guerri A, Gabbiani C, Messori L. Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand. Journal of Inorganic Biochemistry. 105: 348-55. PMID 21421122 DOI: 10.1016/j.jinorgbio.2010.11.016  0.311
2011 Mügge C, Rothenburger C, Beyer A, Görls H, Gabbiani C, Casini A, Michelucci E, Landini I, Nobili S, Mini E, Messori L, Weigand W. Structure, solution chemistry, antiproliferative actions and protein binding properties of non-conventional platinum(II) compounds with sulfur and phosphorus donors. Dalton Transactions (Cambridge, England : 2003). 40: 2006-16. PMID 21212880 DOI: 10.1039/C0Dt00845A  0.548
2011 Marcon G, Casini A, Mura P, Messori L, Bergamo A, Orioli P. Biological Properties of IRIM, the Iridium(III) Analogue of (Imidazolium (Bisimidazole) Tetrachlororuthenate) (ICR). Metal-Based Drugs. 7: 195-200. PMID 18475945 DOI: 10.1155/Mbd.2000.195  0.508
2011 Ascone I, Messori L, Balerna A, Castellano C, Gabbiani C, Casini A, Marchioni C, Castellano AC. XAS/XRD complementary data on metallodrugs and their proteins complexes Acta Crystallographica Section A. 67: 517-517. DOI: 10.1107/S0108767311086909  0.49
2011 Gabbiani C, Mastrobuoni G, Sorrentino F, Dani B, Rigobello MP, Bindoli A, Cinellu MA, Pieraccini G, Messori L, Casini A. Thioredoxin reductase, an emerging target for anticancer metallodrugs. Enzyme inhibition by cytotoxic gold(iii) compounds studied with combined mass spectrometry and biochemical assays Medchemcomm. 2: 50-54. DOI: 10.1039/C0Md00181C  0.554
2010 Messori L, Casini A, Gabbiani C, Michelucci E, Cubo L, Ríos-Luci C, Padrón JM, Navarro-Ranninger C, Quiroga AG. Cytotoxic Profile and Peculiar Reactivity with Biomolecules of a Novel "Rule-Breaker" Iodidoplatinum(II) Complex. Acs Medicinal Chemistry Letters. 1: 381-5. PMID 24900222 DOI: 10.1021/Ml100081E  0.543
2010 Cinellu MA, Maiore L, Manassero M, Casini A, Arca M, Fiebig HH, Kelter G, Michelucci E, Pieraccini G, Gabbiani C, Messori L. [Au2(phen(2Me))2(μ-O)2](PF6)2, a Novel Dinuclear Gold(III) Complex Showing Excellent Antiproliferative Properties. Acs Medicinal Chemistry Letters. 1: 336-9. PMID 24900215 DOI: 10.1021/Ml100097F  0.582
2010 Messori L, Balerna A, Ascone I, Castellano C, Gabbiani C, Casini A, Marchioni C, Jaouen G, Congiu Castellano A. X-ray absorption spectroscopy studies of the adducts formed between cytotoxic gold compounds and two major serum proteins. Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. 16: 491-9. PMID 21181484 DOI: 10.1007/S00775-010-0748-5  0.534
2010 Casini A, Temperini C, Gabbiani C, Supuran CT, Messori L. The x-ray structure of the adduct between NAMI-A and carbonic anhydrase provides insights into the reactivity of this metallodrug with proteins. Chemmedchem. 5: 1989-94. PMID 20931644 DOI: 10.1002/Cmdc.201000331  0.488
2010 Casini A, Edafe F, Erlandsson M, Gonsalvi L, Ciancetta A, Re N, Ienco A, Messori L, Peruzzini M, Dyson PJ. Rationalization of the inhibition activity of structurally related organometallic compounds against the drug target cathepsin B by DFT. Dalton Transactions (Cambridge, England : 2003). 39: 5556-63. PMID 20467693 DOI: 10.1039/C003218B  0.541
2010 Innocenti M, Salvietti E, Guidotti M, Casini A, Bellandi S, Foresti ML, Gabbiani C, Pozzi A, Zatta P, Messori L. Trace copper(II) or zinc(II) ions drastically modify the aggregation behavior of amyloid-beta1-42: an AFM study. Journal of Alzheimer's Disease : Jad. 19: 1323-9. PMID 20061619 DOI: 10.3233/Jad-2010-1338  0.446
2010 Mura P, Camalli M, Casini A, Gabbiani C, Messori L. Trans-cis-cis-[RuCl2(DMSO)2(2-amino-5-methyl-thiazole)2], (PMRu52), a novel ruthenium(II) compound acting as a strong inhibitor of cathepsin B. Journal of Inorganic Biochemistry. 104: 111-7. PMID 19939460 DOI: 10.1016/J.Jinorgbio.2009.10.002  0.556
2010 Nobili S, Mini E, Landini I, Gabbiani C, Casini A, Messori L. Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies. Medicinal Research Reviews. 30: 550-80. PMID 19634148 DOI: 10.1002/Med.20168  0.525
2010 Messori L, Marcon G, Orioli P. Gold(III) compounds as new family of anticancer drugs. Bioinorganic Chemistry and Applications. 177-87. PMID 18365052 DOI: 10.1155/S1565363303000141  0.335
2010 BERTINI I, MESSORI L, VIEZZOLI MS. ChemInform Abstract: Coordination Compounds and Life Processes Cheminform. 24: no-no. DOI: 10.1002/chin.199312326  0.358
2009 Casini A, Karotki A, Gabbiani C, Rugi F, Vašák M, Messori L, Dyson PJ. Reactivity of an antimetastatic organometallic ruthenium compound with metallothionein-2: relevance to the mechanism of action. Metallomics : Integrated Biometal Science. 1: 434-41. PMID 21305148 DOI: 10.1039/B909185H  0.513
2009 Cubo L, Casini A, Gabbiani C, Mastrobuoni G, Messori L, Jiménez-Barbero J, Navarro-Ranninger C, Quiroga AG. Solution behaviour and biomolecular interactions of two cytotoxic trans-platinum(II) complexes bearing aliphatic amine ligands Chemistry (Weinheim An Der Bergstrasse, Germany). 15: 9139-9146. PMID 19655350 DOI: 10.1002/Chem.200901090  0.559
2009 Casini A, Kelter G, Gabbiani C, Cinellu MA, Minghetti G, Fregona D, Fiebig HH, Messori L. Chemistry, antiproliferative properties, tumor selectivity, and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic study. Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. 14: 1139-49. PMID 19543922 DOI: 10.1007/S00775-009-0558-9  0.541
2009 Grossi C, Francese S, Casini A, Rosi MC, Luccarini I, Fiorentini A, Gabbiani C, Messori L, Moneti G, Casamenti F. Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 17: 423-40. PMID 19363260 DOI: 10.3233/Jad-2009-1063  0.459
2009 Casini A, Gabbiani C, Michelucci E, Pieraccini G, Moneti G, Dyson PJ, Messori L. Exploring metallodrug-protein interactions by mass spectrometry: comparisons between platinum coordination complexes and an organometallic ruthenium compound. Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. 14: 761-70. PMID 19288144 DOI: 10.1007/S00775-009-0489-5  0.548
2009 Gabbiani C, Messori L, Cinellu MA, Casini A, Mura P, Sannella AR, Severini C, Majori G, Bilia AR, Vincieri FF. Outstanding plasmodicidal properties within a small panel of metallic compounds: Hints for the development of new metal-based antimalarials. Journal of Inorganic Biochemistry. 103: 310-2. PMID 19027959 DOI: 10.1016/J.Jinorgbio.2008.10.004  0.544
2009 Bindoli A, Rigobello MP, Scutari G, Gabbiani C, Casini A, Messori L. Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs Coordination Chemistry Reviews. 253: 1692-1707. DOI: 10.1016/J.Ccr.2009.02.026  0.532
2008 Hartinger CG, Casini A, Duhot C, Tsybin YO, Messori L, Dyson PJ. Stability of an organometallic ruthenium-ubiquitin adduct in the presence of glutathione: relevance to antitumour activity. Journal of Inorganic Biochemistry. 102: 2136-41. PMID 18834634 DOI: 10.1016/J.Jinorgbio.2008.08.002  0.539
2008 Casini A, Gabbiani C, Sorrentino F, Rigobello MP, Bindoli A, Geldbach TJ, Marrone A, Re N, Hartinger CG, Dyson PJ, Messori L. Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compounds. Journal of Medicinal Chemistry. 51: 6773-81. PMID 18834187 DOI: 10.1021/Jm8006678  0.532
2008 Chiellini C, Casini A, Cochet O, Gabbiani C, Ailhaud G, Dani C, Messori L, Amri EZ. The influence of auranofin, a clinically established antiarthritic gold drug, on bone metabolism: analysis of its effects on human multipotent adipose-derived stem cells, taken as a model. Chemistry & Biodiversity. 5: 1513-20. PMID 18729088 DOI: 10.1002/Cbdv.200890140  0.434
2008 Ascone I, Messori L, Casini A, Gabbiani C, Balerna A, Dell'Unto F, Castellano AC. Exploiting soft and hard X-ray absorption spectroscopy to characterize metallodrug/protein interactions: the binding of [trans-RuCl4(Im)(dimethylsulfoxide)][ImH] (Im = imidazole) to bovine serum albumin. Inorganic Chemistry. 47: 8629-34. PMID 18722420 DOI: 10.1021/Ic8001477  0.489
2008 Gabbiani C, Casini A, Mastrobuoni G, Kirshenbaum N, Moshel O, Pieraccini G, Moneti G, Messori L, Gibson D. Peculiar mechanistic and structural features of the carboplatin-cytochrome c system revealed by ESI-MS analysis Journal of Biological Inorganic Chemistry. 13: 755-764. PMID 18350322 DOI: 10.1007/S00775-008-0361-Z  0.513
2008 Gabbiani C, Casini A, Messori L, Guerri A, Cinellu MA, Minghetti G, Corsini M, Rosani C, Zanello P, Arca M. Structural characterization, solution studies, and DFT calculations on a series of binuclear gold(III) oxo complexes: relationships to biological properties. Inorganic Chemistry. 47: 2368-79. PMID 18314951 DOI: 10.1021/Ic701254S  0.506
2008 Sannella AR, Casini A, Gabbiani C, Messori L, Bilia AR, Vincieri FF, Majori G, Severini C. New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro: Mechanistic and pharmacological implications. Febs Letters. 582: 844-7. PMID 18294965 DOI: 10.1016/J.Febslet.2008.02.028  0.481
2008 Casini A, Guerri A, Gabbiani C, Messori L. Biophysical characterisation of adducts formed between anticancer metallodrugs and selected proteins: new insights from X-ray diffraction and mass spectrometry studies. Journal of Inorganic Biochemistry. 102: 995-1006. PMID 18289690 DOI: 10.1016/J.Jinorgbio.2007.12.022  0.528
2008 Casini A, Hartinger C, Gabbiani C, Mini E, Dyson PJ, Keppler BK, Messori L. Gold(III) compounds as anticancer agents: relevance of gold-protein interactions for their mechanism of action. Journal of Inorganic Biochemistry. 102: 564-75. PMID 18177942 DOI: 10.1016/J.Jinorgbio.2007.11.003  0.571
2008 Drago D, Bettella M, Bolognin S, Cendron L, Scancar J, Milacic R, Ricchelli F, Casini A, Messori L, Tognon G, Zatta P. Potential pathogenic role of beta-amyloid(1-42)-aluminum complex in Alzheimer's disease. The International Journal of Biochemistry & Cell Biology. 40: 731-46. PMID 18060826 DOI: 10.1016/J.Biocel.2007.10.014  0.426
2008 Bilia AR, Sannella AR, Vincieri FF, Messori L, Casini A, Gabbiani C, Severini C, Majori G. Antiplasmodial Effects of a few Selected Natural Flavonoids and their Modulation of Artemisinin Activity Natural Product Communications. 3: 1934578X0800301. DOI: 10.1177/1934578X0800301212  0.428
2008 Muniz-Miranda M, Pagliai M, Cardini G, Messori L, Bruni B, Casini A, Vaira MD, Schettino V. A multi-technique approach to predicting the molecular structure of cuprizone in the gas phase and in the crystalline state Crystengcomm. 10: 416-422. DOI: 10.1039/B715131D  0.45
2007 Pratesi A, Zanello P, Giorgi G, Messori L, Laschi F, Casini A, Corsini M, Gabbiani C, Orfei M, Rosani C, Ginanneschi M. New copper(II)/cyclic tetrapeptide system that easily oxidizes to copper(III) under atmospheric oxygen. Inorganic Chemistry. 46: 10038-40. PMID 17979273 DOI: 10.1021/Ic701411Y  0.489
2007 Mura P, Camalli M, Bindoli A, Sorrentino F, Casini A, Gabbiani C, Corsini M, Zanello P, Rigobello MP, Messori L. Activity of rat cytosolic thioredoxin reductase is strongly decreased by trans-[bis(2-amino-5- methylthiazole)tetrachlororuthenate(III)]: first report of relevant thioredoxin reductase inhibition for a ruthenium compound. Journal of Medicinal Chemistry. 50: 5871-4. PMID 17975904 DOI: 10.1021/Jm0708578  0.538
2007 Casini A, Gabbiani C, Mastrobuoni G, Pellicani RZ, Intini FP, Arnesano F, Natile G, Moneti G, Francese S, Messori L. Insights into the molecular mechanisms of protein platination from a case study: The reaction of anticancer platinum(II) iminoethers with horse heart cytochrome C Biochemistry. 46: 12220-12230. PMID 17924668 DOI: 10.1021/Bi701516Q  0.519
2007 Casini A, Mastrobuoni G, Terenghi M, Gabbiani C, Monzani E, Moneti G, Casella L, Messori L. Ruthenium anticancer drugs and proteins: A study of the interactions of the ruthenium(III) complex imidazolium trans-[tetrachloro(dimethyl sulfoxide)(imidazole)ruthenate(III)] with hen egg white lysozyme and horse heart cytochrome c Journal of Biological Inorganic Chemistry. 12: 1107-1117. PMID 17680283 DOI: 10.1007/S00775-007-0280-4  0.555
2007 Messori L, Casini A, Gabbiani C, Sorace L, Muniz-Miranda M, Zatta P. Unravelling the chemical nature of copper cuprizone. Dalton Transactions (Cambridge, England : 2003). 2112-4. PMID 17514330 DOI: 10.1039/B701896G  0.467
2007 Casini A, Mastrobuoni G, Ang WH, Gabbiani C, Pieraccini G, Moneti G, Dyson PJ, Messori L. ESI-MS characterisation of protein adducts of anticancer ruthenium(II)-arene PTA (RAPTA) complexes Chemmedchem. 2: 631-635. PMID 17366652 DOI: 10.1002/Cmdc.200600258  0.551
2007 Ciani L, Casini A, Gabbiani C, Ristori S, Messori L, Martini G. DOTAP/DOPE and DC-Chol/DOPE lipoplexes for gene delivery studied by circular dichroism and other biophysical techniques. Biophysical Chemistry. 127: 213-20. PMID 17350156 DOI: 10.1016/J.Bpc.2007.02.003  0.452
2007 Cini R, Defazio S, Tamasi G, Casolaro M, Messori L, Casini A, Morpurgo M, Hursthouse M. fac-{Ru(CO)3}2+-core complexes and design of metal-based drugs. synthesis, structure, and reactivity of Ru-thiazole derivative with serum proteins and absorption-release studies with acryloyl and silica hydrogels as carriers in physiological media. Inorganic Chemistry. 46: 79-92. PMID 17198415 DOI: 10.1021/Ic060755S  0.538
2007 Casini A, Mastrobuoni G, Temperini C, Gabbiani C, Francese S, Moneti G, Supuran CT, Scozzafava A, Messori L. ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme Chemical Communications. 156-158. PMID 17180231 DOI: 10.1039/B611122J  0.479
2007 Sannella AR, Messori L, Casini A, Francesco Vincieri F, Bilia AR, Majori G, Severini C. Antimalarial properties of green tea. Biochemical and Biophysical Research Communications. 353: 177-81. PMID 17174271 DOI: 10.1016/J.Bbrc.2006.12.005  0.431
2007 Sannella A, Messori L, Casini A, Vincieri F, Maiori G, Severini C, Bilia A. Modulation of the in vitro antimalarial effects of artemisinin by selected flavonoids and by reducing agents Planta Medica. 73. DOI: 10.1055/S-2007-986916  0.438
2007 Hartinger CG, Ang WH, Casini A, Messori L, Keppler BK, Dyson PJ. Mass spectrometric analysis of ubiquitin–platinum interactions of leading anticancer drugs: MALDI versus ESI Journal of Analytical Atomic Spectrometry. 22: 960-967. DOI: 10.1039/B703350H  0.51
2007 Gabbiani C, Casini A, Messori L. Gold(III) compounds as anticancer drugs Gold Bulletin. 40: 73-81. DOI: 10.1007/Bf03215296  0.57
2006 Casini A, Cinellu MA, Minghetti G, Gabbiani C, Coronnello M, Mini E, Messori L. Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold(III) compounds with bipyridyl ligands. Journal of Medicinal Chemistry. 49: 5524-31. PMID 16942025 DOI: 10.1021/Jm060436A  0.555
2006 Casini A, Gabbiani C, Mastrobuoni G, Messori L, Moneti G, Pieraccini G. Exploring metallodrug-protein interactions by ESI mass spectrometry: the reaction of anticancer platinum drugs with horse heart cytochrome c Chemmedchem. 1: 413-417. PMID 16892376 DOI: 10.1002/Cmdc.200500079  0.472
2006 Calderone V, Casini A, Mangani S, Messori L, Orioli PL. Structural investigation of cisplatin-protein interactions: selective platination of His19 in a cuprozinc superoxide dismutase. Angewandte Chemie (International Ed. in English). 45: 1267-9. PMID 16416478 DOI: 10.1002/Anie.200502599  0.488
2006 Messori L, Gabbiani C, Casini A, Siragusa M, Vincieri FF, Bilia AR. The reaction of artemisinins with hemoglobin: a unified picture. Bioorganic & Medicinal Chemistry. 14: 2972-7. PMID 16412643 DOI: 10.1016/J.Bmc.2005.12.038  0.473
2005 Piccioli F, Sabatini S, Messori L, Orioli P, Hartinger ChG, Keppler BK. A comparative study of adduct formation between the anticancer ruthenium(III) compound HInd trans-[RuCl4(Ind)2] and serum proteins. Journal of Inorganic Biochemistry. 98: 1135-42. PMID 15149825 DOI: 10.1016/J.JINORGBIO.2004.04.002  0.317
2004 Mura P, Camalli M, Messori L, Piccioli F, Zanello P, Corsini M. Synthesis, structural characterization, solution chemistry, and preliminary biological studies of the ruthenium(III) complexes [TzH][trans-RuCl4(Tz)2] and [TzH][trans-RuCl4(DMSO)(Tz)].(DMSO), the thiazole analogues of antitumor ICR and NAMI-A. Inorganic Chemistry. 43: 3863-70. PMID 15206867 DOI: 10.1021/IC0354116  0.324
2002 Marcon G, Messori L, Orioli P. Gold(III) complexes as a new family of cytotoxic and antitumor agents. Expert Review of Anticancer Therapy. 2: 337-46. PMID 12113057 DOI: 10.1586/14737140.2.3.337  0.311
2002 Marcon G, Carotti S, Coronnello M, Messori L, Mini E, Orioli P, Mazzei T, Cinellu MA, Minghetti G. Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties. Journal of Medicinal Chemistry. 45: 1672-7. PMID 11931621 DOI: 10.1021/JM010997W  0.311
2001 Casini A, Messori L, Orioli P, Gielen M, Kemmer M, Willem R. Interactions of two cytotoxic organotin(IV) compounds with calf thymus DNA. Journal of Inorganic Biochemistry. 85: 297-300. PMID 11551387 DOI: 10.1016/S0162-0134(01)00215-X  0.503
2001 Mura P, Casini A, Marcon G, Messori L. Synthesis, molecular structure and solution chemistry of the iridium(III) complex imidazolium [trans(bisimidazole)tetrachloro iridate(III)] (IRIM) Inorganica Chimica Acta. 312: 74-80. DOI: 10.1016/S0020-1693(00)00330-3  0.531
2000 Gallori E, Vettori C, Alessio E, Vilchez FG, Vilaplana R, Orioli P, Casini A, Messori L. DNA as a Possible Target for Antitumor Ruthenium(III) Complexes: A Spectroscopic and Molecular Biology Study of the Interactions of Two Representative Antineoplastic Ruthenium(III) Complexes with DNA Archives of Biochemistry and Biophysics. 376: 156-162. PMID 10729201 DOI: 10.1006/Abbi.1999.1654  0.516
2000 Ottaviani MF, Furini F, Casini A, Turro NJ, Jockusch S, Tomalia DA, Messori L. Formation of supramolecular structures between DNA and starburst dendrimers studied by EPR, CD, UV, and melting profiles Macromolecules. 33: 7842-7851. DOI: 10.1021/Ma000877I  0.469
2000 Messori L, Casini A, Vullo D, Haroutiunian S, Dalian E, Orioli P. Effects of two representative antitumor ruthenium(III) complexes on thermal denaturation profiles of DNA Inorganica Chimica Acta. 303: 283-286. DOI: 10.1016/S0020-1693(99)00528-9  0.509
1998 Gonzalez Vilchez F, Vilaplana R, Blasco G, Messori L. Solution studies of the antitumor complex dichloro 1,2-propylendiaminetetraacetate ruthenium (III) and of its interactions with proteins. Journal of Inorganic Biochemistry. 71: 45-51. PMID 9755491 DOI: 10.1016/S0162-0134(98)10031-4  0.332
1997 Calamai P, Carotti S, Guerri A, Messori L, Mini E, Orioli P, Speroni GP. Biological properties of two gold(III) complexes: AuCl3(Hpm) and AuCl2(pm). Journal of Inorganic Biochemistry. 66: 103-9. PMID 9112761 DOI: 10.1016/S0162-0134(96)00190-0  0.328
1995 Golub G, Cohen H, Paoletti P, Bencini A, Messori L, Bertini I, Meyerstein D. Use of Hydrophobic Ligands for the Stabilization of Low-Valent Transition Metal Complexes. 1. The Effect of N-Methylation of Linear Tetraazaalkane Ligands on the Properties of Their Copper Complexes Journal of the American Chemical Society. 117: 8353-8361. DOI: 10.1021/Ja00137A008  0.392
1995 Bertini I, Galas O, Luchinat C, Messori L, Parigi G. A theoretical analysis of the 1H nuclear magnetic relaxation dispersion profiles of diferric transferrin The Journal of Physical Chemistry. 99: 14217-14222. DOI: 10.1021/J100039A006  0.301
1995 Bertini I, Messori L, Golub G, Cohen H, Meyerstein D. A 1H NMR study of the complex of cobalt(II) with 2,5,8,11-tetramethyl-2,5,8,11-tetraazadodecane in aerated aqueous solutions Inorganica Chimica Acta. 235: 5-8. DOI: 10.1016/0020-1693(95)90038-8  0.447
1993 Bertini I, Luchinat C, Messori L, Vasak M. A two-dimensional NMR study of Co(II)7 rabbit liver metallothionein. European Journal of Biochemistry. 211: 235-40. PMID 8425533 DOI: 10.1111/J.1432-1033.1993.Tb19891.X  0.392
1993 Bertini I, Briganti F, Calzolai L, Messori L, Scozzafava A. Selective interaction of ferricyanide with cluster I of Clostridium pasteurianum 2[Fe4S4] ferredoxin. Febs Letters. 332: 268-72. PMID 8405469 DOI: 10.1016/0014-5793(93)80647-D  0.323
1993 Rüterjans H, Messori L, Ohlenschläger O, Briganti F, Bertini I. 1H NMR studies on reduced high potential iron protein (HIPIP) from Chromatium Vinosum Applied Magnetic Resonance. 4: 477-489. DOI: 10.1007/Bf03162461  0.38
1993 Banci L, Bertini I, Luchinat C, Messori L, Turano P. Frontiers in 2D NMR of paramagnetic metalloproteins Applied Magnetic Resonance. 4: 461-476. DOI: 10.1007/Bf03162460  0.394
1992 Auld DS, Bertini I, Donaire A, Messori L, Moratal JM. pH-dependent properties of cobalt(II) carboxypeptidase A - Inhibitor complexes Biochemistry. 31: 3840-3846. PMID 1567840 DOI: 10.1021/Bi00130A015  0.4
1992 Bertini I, Briganti F, Luchinat C, Messori L, Monnanni R, Scozzafava A, Vallini G. 1H-NMR studies on partially and fully reduced 2(4Fe-4S) ferredoxin from Clostridium pasteurianum. European Journal of Biochemistry. 204: 831-9. PMID 1541295 DOI: 10.1111/J.1432-1033.1992.Tb16702.X  0.374
1992 Bertini I, Capozzi F, Ciurli S, Luchinat C, Messori L, Piccioli M. Identification of the iron ions of high potential iron protein from Chromatium vinosum within the protein frame through two-dimensional NMR experiments Journal of the American Chemical Society. 114: 3332-3340. DOI: 10.1021/ja00035a026  0.56
1992 Bertini I, Messori L, Viezzoli MS. Coordination compounds and life processes Coordination Chemistry Reviews. 120: 163-192. DOI: 10.1016/0010-8545(92)80050-2  0.427
1991 Bertini I, Briganti F, Luchinat C, Messori L, Monnanni R, Scozzafava A, Vallini G. 2D 1H NMR studies of oxidized 2(Fe4S4) ferredoxin from Clostridium pasteurianum. Febs Letters. 289: 253-6. PMID 1915855 DOI: 10.1016/0014-5793(91)81082-J  0.343
1991 Bertini I, Messori L, Monnanni R, Scozzafaya A. 2D 1H NMR investigations of paramagnetic proteins: The oxidized form of ferredoxin from clostridium pasteurianum. Journal of Inorganic Biochemistry. 43: 259. DOI: 10.1016/0162-0134(91)84249-9  0.372
1990 Bertini I, Donaire A, Messori L, Moratal J. Interaction of phosphate and pyrophosphate with cobalt(II) carboxypeptidase Inorganic Chemistry. 29: 202-205. DOI: 10.1021/Ic00327A011  0.374
1989 Bertini I, Hirose J, Messori L, Monnanni R. A 1H NMR study of cobalt(II) arsanilazocarboxypeptidase A. Journal of Inorganic Biochemistry. 35: 225-30. PMID 2723628 DOI: 10.1016/0162-0134(89)84012-7  0.427
1989 Bertini I, Luchinat C, Messori L, Vasak M. Proton NMR spectra of the Co4S11 cluster in metallothioneins: a theoretical model Journal of the American Chemical Society. 111: 7300-7303. DOI: 10.1021/Ja00201A003  0.328
1989 Bertini I, Luchinat C, Messori L, Vasak M. Proton NMR studies of the cobalt(II)-metallothionein system Journal of the American Chemical Society. 111: 7296-7300. DOI: 10.1021/Ja00201A002  0.401
1989 Bertini I, Mangani S, Messori L, Orioli P. An EXAFS study on the interaction between serum transferrin and oxalate as synergistic anion Journal of Inorganic Biochemistry. 36: 189. DOI: 10.1016/0162-0134(89)84130-3  0.331
1989 Bertini I, Luchinat C, Messori L, Vasak M. Proton NMR and NOE studies on the cobalt(II) derivative of rabbit metallothionein Journal of Inorganic Biochemistry. 36: 187. DOI: 10.1016/0162-0134(89)84122-4  0.409
1988 Bertini I, Luchinat C, Messori L, Monnanni R, Auld DS, Riordan JF. 1H NMR spectroscopic characterization of binary and ternary complexes of cobalt(II) carboxypeptidase A with inhibitors Biochemistry. 27: 8318-8325. PMID 3242589 DOI: 10.1021/Bi00422A005  0.454
1988 Bertini I, Luchinat C, Messori L. Role of aminoacidic residues inside active sites of metalloproteins Pure and Applied Chemistry. 60: 1261-1266. DOI: 10.1351/Pac198860081261  0.394
1988 Bertini I, Hirose J, Luchinat C, Messori L, Piccioli M, Scozzafava A. Kinetic studies on metal removal from transferrins by pyrophosphate. Investigation on iron(III) and manganese(III) derivatives Inorganic Chemistry. 27: 2405-2409. DOI: 10.1021/Ic00287A009  0.368
1988 Bertini I, Hirose J, Kozlowski H, Luchinat C, Messori L, Scozzafava A. Effect of nonsynergistic anions on copper transferrin Inorganic Chemistry. 27: 1081-1086. DOI: 10.1021/Ic00279A029  0.326
1988 Bertini I, Messori L, Pellacani GC, Sola M. Evidence of a metal-synergistic anion bond in thallium(III) transferrin Inorganic Chemistry. 27: 761-762. DOI: 10.1021/Ic00277A038  0.347
1986 BERTINI I, MANGANI S, MESSORI L, MOBILLO S, ORIOLI PL. EXAFS INVESTIGATIONS ON A N-TERMINAL FRAGMENT OF HUMAN TRANSFERRIN CONTAINING A SINGLE IRON BINDING SITE Le Journal De Physique Colloques. 47: C8-1193-C8-1196. DOI: 10.1051/Jphyscol:19868234  0.322
1986 Bertini I, Luchinat C, Messori L, Scozzafava A, Pellacani G, Sola M. Carbon-13 NMR study of the synergistic anion in transferrins Inorganic Chemistry. 25: 1782-1786. DOI: 10.1021/Ic00231A013  0.32
1985 Bertini I, Luchinat C, Messori L. Spectral characterization of vanadium-transferrin systems. Journal of Inorganic Biochemistry. 25: 57-60. PMID 4045451 DOI: 10.1016/0162-0134(85)83008-7  0.373
1985 Bertini I, Lanini G, Luchinat C, Messori L, Monnanni R, Scozzafava A. Investigation of Cu2Co2SOD and its anion derivatives. Proton NMR and electronic spectra Journal of the American Chemical Society. 107: 4391-4396. DOI: 10.1021/Ja00301A004  0.352
1985 BERTINI I, LANINI G, LUCHINAT C, MESSORI L, MONNANNI R, SCOZZAFAVA A. ChemInform Abstract: INVESTIGATION OF CU2CO2SOD AND ITS ANION DERIVATIVES. PROTON NMR AND ELECTRONIC SPECTRA Chemischer Informationsdienst. 16. DOI: 10.1002/chin.198545311  0.352
1984 Bertini I, Luchinat C, Messori L, Scozzafava A. Cobalt(II) as an NMR probe for the investigation of the coordination sites of conalbumin. European Journal of Biochemistry. 141: 375-8. PMID 6734602 DOI: 10.1111/J.1432-1033.1984.Tb08201.X  0.41
1983 Bertini I, Luchinat C, Messori L. Thallium-205 as an NMR probe for the investigation of transferrin Journal of the American Chemical Society. 105: 1347-1350. DOI: 10.1002/Chin.198326044  0.348
1983 BERTINI I, LUCHINAT C, MESSORI L. ChemInform Abstract: THALLIUM-205 AS AN NMR PROBE FOR THE INVESTIGATION OF TRANSFERRIN Chemischer Informationsdienst. 14. DOI: 10.1002/chin.198326044  0.347
1982 Bertini I, Luchinat C, Messori L. A water 17O NMR study of the pH dependent properties of superoxide dismutase. Biochemical and Biophysical Research Communications. 101: 577-83. PMID 7306097 DOI: 10.1016/0006-291X(81)91298-5  0.35
1982 Bertini I, Canti G, Luchinat C, Messori L. 1H NMR detection of CoOH2 .dblharw. CoOH interconversions in high-spin cobalt(II) complexes Inorganic Chemistry. 21: 3426-3429. DOI: 10.1021/Ic00139A031  0.378
Show low-probability matches.